Serveur d'exploration sur la grippe en Espagne

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study.

Identifieur interne : 000185 ( Main/Exploration ); précédent : 000184; suivant : 000186

Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study.

Auteurs : Jesús Castilla ; Marcela Guevara ; Iván Martínez-Baz ; Carmen Ezpeleta ; Josu Delfrade ; Fátima Irisarri ; Conchi Moreno-Iribas

Source :

RBID : pubmed:26222861

Descripteurs français

English descriptors

Abstract

Mortality is a major end-point in the evaluation of influenza vaccine effectiveness. However, this effect is not well known, since most previous studies failed to show good control of biases. We aimed to estimate the effectiveness of influenza vaccination in preventing all-cause mortality in community-dwelling seniors.Since 2009, a population-based cohort study using healthcare databases has been conducted in Navarra, Spain. In 2 late influenza seasons, 2011/2012 and 2012/2013, all-cause mortality in the period January to May was compared between seniors (65 years or over) who received the trivalent influenza vaccine and those who were unvaccinated, adjusting for demographics, major chronic conditions, dependence, previous hospitalization, and pneumococcal vaccination.The cohort included 103,156 seniors in the 2011/2012 season and 105,140 in the 2012/2013 season (58% vaccinated). Seniors vaccinated in the previous season who discontinued vaccination (6% of the total) had excess mortality and were excluded to prevent frailty bias. The final analysis included 80,730 person-years and 2778 deaths. Vaccinated seniors had 16% less all-cause mortality than those unvaccinated (adjusted rate ratio [RR] = 0.84; 95% confidence interval 0.76-0.93). This association disappeared in the post-influenza period (adjusted RR = 0.96; 95% confidence interval 0.85-1.09). A similar comparison did not find an association in January to May of the 2009/2010 pandemic season (adjusted RR = 0.98; 95% confidence interval 0.84-1.14), when no effect of the seasonal vaccine was expected. On average, 1 death was prevented for every 328 seniors vaccinated: 1 for every 649 in the 65 to 74 year age group and 1 for every 251 among those aged 75 and over.These results suggest a moderate preventive effect and a high potential impact of the seasonal influenza vaccine against all-cause mortality. This reinforces the recommendation of annual influenza vaccination in seniors.

DOI: 10.1097/MD.0000000000001240
PubMed: 26222861
PubMed Central: PMC4554121


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study.</title>
<author>
<name sortKey="Castilla, Jesus" sort="Castilla, Jesus" uniqKey="Castilla J" first="Jesús" last="Castilla">Jesús Castilla</name>
<affiliation>
<nlm:affiliation>From the Instituto de Salud Pública de Navarra, IdiSNA - Navarra Institute for Health Research (JC, MG, IM-B, JD, FI, CM-I); CIBER Epidemiología y Salud Pública (JC, MG, IM-B, JD, FI); Complejo Hospitalario de Navarra, IdiSNA - Navarra Institute for Health Research (CE); and Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Pamplona, Spain (CM-I).</nlm:affiliation>
<wicri:noCountry code="subField">Spain (CM-I)</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Guevara, Marcela" sort="Guevara, Marcela" uniqKey="Guevara M" first="Marcela" last="Guevara">Marcela Guevara</name>
</author>
<author>
<name sortKey="Martinez Baz, Ivan" sort="Martinez Baz, Ivan" uniqKey="Martinez Baz I" first="Iván" last="Martínez-Baz">Iván Martínez-Baz</name>
</author>
<author>
<name sortKey="Ezpeleta, Carmen" sort="Ezpeleta, Carmen" uniqKey="Ezpeleta C" first="Carmen" last="Ezpeleta">Carmen Ezpeleta</name>
</author>
<author>
<name sortKey="Delfrade, Josu" sort="Delfrade, Josu" uniqKey="Delfrade J" first="Josu" last="Delfrade">Josu Delfrade</name>
</author>
<author>
<name sortKey="Irisarri, Fatima" sort="Irisarri, Fatima" uniqKey="Irisarri F" first="Fátima" last="Irisarri">Fátima Irisarri</name>
</author>
<author>
<name sortKey="Moreno Iribas, Conchi" sort="Moreno Iribas, Conchi" uniqKey="Moreno Iribas C" first="Conchi" last="Moreno-Iribas">Conchi Moreno-Iribas</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26222861</idno>
<idno type="pmid">26222861</idno>
<idno type="doi">10.1097/MD.0000000000001240</idno>
<idno type="pmc">PMC4554121</idno>
<idno type="wicri:Area/Main/Corpus">00163</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00163</idno>
<idno type="wicri:Area/Main/Curation">000163</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000163</idno>
<idno type="wicri:Area/Main/Exploration">000163</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study.</title>
<author>
<name sortKey="Castilla, Jesus" sort="Castilla, Jesus" uniqKey="Castilla J" first="Jesús" last="Castilla">Jesús Castilla</name>
<affiliation>
<nlm:affiliation>From the Instituto de Salud Pública de Navarra, IdiSNA - Navarra Institute for Health Research (JC, MG, IM-B, JD, FI, CM-I); CIBER Epidemiología y Salud Pública (JC, MG, IM-B, JD, FI); Complejo Hospitalario de Navarra, IdiSNA - Navarra Institute for Health Research (CE); and Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Pamplona, Spain (CM-I).</nlm:affiliation>
<wicri:noCountry code="subField">Spain (CM-I)</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Guevara, Marcela" sort="Guevara, Marcela" uniqKey="Guevara M" first="Marcela" last="Guevara">Marcela Guevara</name>
</author>
<author>
<name sortKey="Martinez Baz, Ivan" sort="Martinez Baz, Ivan" uniqKey="Martinez Baz I" first="Iván" last="Martínez-Baz">Iván Martínez-Baz</name>
</author>
<author>
<name sortKey="Ezpeleta, Carmen" sort="Ezpeleta, Carmen" uniqKey="Ezpeleta C" first="Carmen" last="Ezpeleta">Carmen Ezpeleta</name>
</author>
<author>
<name sortKey="Delfrade, Josu" sort="Delfrade, Josu" uniqKey="Delfrade J" first="Josu" last="Delfrade">Josu Delfrade</name>
</author>
<author>
<name sortKey="Irisarri, Fatima" sort="Irisarri, Fatima" uniqKey="Irisarri F" first="Fátima" last="Irisarri">Fátima Irisarri</name>
</author>
<author>
<name sortKey="Moreno Iribas, Conchi" sort="Moreno Iribas, Conchi" uniqKey="Moreno Iribas C" first="Conchi" last="Moreno-Iribas">Conchi Moreno-Iribas</name>
</author>
</analytic>
<series>
<title level="j">Medicine</title>
<idno type="eISSN">1536-5964</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged (MeSH)</term>
<term>Cause of Death (trends)</term>
<term>Female (MeSH)</term>
<term>Follow-Up Studies (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Male (MeSH)</term>
<term>Pandemics (prevention & control)</term>
<term>Pandemics (statistics & numerical data)</term>
<term>Population Surveillance (MeSH)</term>
<term>Prospective Studies (MeSH)</term>
<term>Spain (epidemiology)</term>
<term>Survival Rate (trends)</term>
<term>Vaccination (statistics & numerical data)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Cause de décès (tendances)</term>
<term>Espagne (épidémiologie)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (prévention et contrôle)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (prévention et contrôle)</term>
<term>Pandémies (statistiques et données numériques)</term>
<term>Sujet âgé (MeSH)</term>
<term>Surveillance de la population (MeSH)</term>
<term>Taux de survie (tendances)</term>
<term>Vaccination (statistiques et données numériques)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Études de suivi (MeSH)</term>
<term>Études prospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Influenza, Human</term>
<term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Influenza, Human</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Grippe humaine</term>
<term>Pandémies</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en">
<term>Pandemics</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr">
<term>Pandémies</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="tendances" xml:lang="fr">
<term>Cause de décès</term>
<term>Taux de survie</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en">
<term>Cause of Death</term>
<term>Survival Rate</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Espagne</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Population Surveillance</term>
<term>Prospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Sujet âgé</term>
<term>Surveillance de la population</term>
<term>Études de suivi</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Mortality is a major end-point in the evaluation of influenza vaccine effectiveness. However, this effect is not well known, since most previous studies failed to show good control of biases. We aimed to estimate the effectiveness of influenza vaccination in preventing all-cause mortality in community-dwelling seniors.Since 2009, a population-based cohort study using healthcare databases has been conducted in Navarra, Spain. In 2 late influenza seasons, 2011/2012 and 2012/2013, all-cause mortality in the period January to May was compared between seniors (65 years or over) who received the trivalent influenza vaccine and those who were unvaccinated, adjusting for demographics, major chronic conditions, dependence, previous hospitalization, and pneumococcal vaccination.The cohort included 103,156 seniors in the 2011/2012 season and 105,140 in the 2012/2013 season (58% vaccinated). Seniors vaccinated in the previous season who discontinued vaccination (6% of the total) had excess mortality and were excluded to prevent frailty bias. The final analysis included 80,730 person-years and 2778 deaths. Vaccinated seniors had 16% less all-cause mortality than those unvaccinated (adjusted rate ratio [RR] = 0.84; 95% confidence interval 0.76-0.93). This association disappeared in the post-influenza period (adjusted RR = 0.96; 95% confidence interval 0.85-1.09). A similar comparison did not find an association in January to May of the 2009/2010 pandemic season (adjusted RR = 0.98; 95% confidence interval 0.84-1.14), when no effect of the seasonal vaccine was expected. On average, 1 death was prevented for every 328 seniors vaccinated: 1 for every 649 in the 65 to 74 year age group and 1 for every 251 among those aged 75 and over.These results suggest a moderate preventive effect and a high potential impact of the seasonal influenza vaccine against all-cause mortality. This reinforces the recommendation of annual influenza vaccination in seniors.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">26222861</PMID>
<DateCompleted>
<Year>2015</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1536-5964</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>94</Volume>
<Issue>30</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Medicine</Title>
<ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>
</Journal>
<ArticleTitle>Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study.</ArticleTitle>
<Pagination>
<MedlinePgn>e1240</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000001240</ELocationID>
<Abstract>
<AbstractText>Mortality is a major end-point in the evaluation of influenza vaccine effectiveness. However, this effect is not well known, since most previous studies failed to show good control of biases. We aimed to estimate the effectiveness of influenza vaccination in preventing all-cause mortality in community-dwelling seniors.Since 2009, a population-based cohort study using healthcare databases has been conducted in Navarra, Spain. In 2 late influenza seasons, 2011/2012 and 2012/2013, all-cause mortality in the period January to May was compared between seniors (65 years or over) who received the trivalent influenza vaccine and those who were unvaccinated, adjusting for demographics, major chronic conditions, dependence, previous hospitalization, and pneumococcal vaccination.The cohort included 103,156 seniors in the 2011/2012 season and 105,140 in the 2012/2013 season (58% vaccinated). Seniors vaccinated in the previous season who discontinued vaccination (6% of the total) had excess mortality and were excluded to prevent frailty bias. The final analysis included 80,730 person-years and 2778 deaths. Vaccinated seniors had 16% less all-cause mortality than those unvaccinated (adjusted rate ratio [RR] = 0.84; 95% confidence interval 0.76-0.93). This association disappeared in the post-influenza period (adjusted RR = 0.96; 95% confidence interval 0.85-1.09). A similar comparison did not find an association in January to May of the 2009/2010 pandemic season (adjusted RR = 0.98; 95% confidence interval 0.84-1.14), when no effect of the seasonal vaccine was expected. On average, 1 death was prevented for every 328 seniors vaccinated: 1 for every 649 in the 65 to 74 year age group and 1 for every 251 among those aged 75 and over.These results suggest a moderate preventive effect and a high potential impact of the seasonal influenza vaccine against all-cause mortality. This reinforces the recommendation of annual influenza vaccination in seniors.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Castilla</LastName>
<ForeName>Jesús</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Instituto de Salud Pública de Navarra, IdiSNA - Navarra Institute for Health Research (JC, MG, IM-B, JD, FI, CM-I); CIBER Epidemiología y Salud Pública (JC, MG, IM-B, JD, FI); Complejo Hospitalario de Navarra, IdiSNA - Navarra Institute for Health Research (CE); and Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Pamplona, Spain (CM-I).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guevara</LastName>
<ForeName>Marcela</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Martínez-Baz</LastName>
<ForeName>Iván</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ezpeleta</LastName>
<ForeName>Carmen</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Delfrade</LastName>
<ForeName>Josu</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Irisarri</LastName>
<ForeName>Fátima</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Moreno-Iribas</LastName>
<ForeName>Conchi</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Medicine (Baltimore)</MedlineTA>
<NlmUniqueID>2985248R</NlmUniqueID>
<ISSNLinking>0025-7974</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011159" MajorTopicYN="Y">Population Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>10</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26222861</ArticleId>
<ArticleId IdType="doi">10.1097/MD.0000000000001240</ArticleId>
<ArticleId IdType="pii">00005792-201507050-00025</ArticleId>
<ArticleId IdType="pmc">PMC4554121</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Epidemiol Rev. 1982;4:25-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6754408</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2004 Sep 18;329(7467):660</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15313884</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1994 Sep 22;331(12):778-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8065407</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2004 Dec 16;351(25):2611-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15602021</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Epidemiol. 2006 Apr;35(2):345-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16368724</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Epidemiol. 2006 Apr;35(2):337-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16368725</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Respir J. 2007 Sep;30(3):414-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17537767</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2007 Oct;7(10):658-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17897608</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2007 Oct 4;357(14):1373-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17914038</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Epidemiol. 2009 Jul;62(7):687-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19124221</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2009 Sep 1;170(5):650-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19625341</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19745214</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2010 Jan 15;201(2):186-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19995265</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2010 Nov 1;51(9):1007-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20887208</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011;6(6):e20661</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21713040</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2011 Aug 11;29(35):5919-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21723358</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011;6(7):e22618</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21818350</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2012;17(14). pii: 20138</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22516003</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2012;17(17). pii: 20154</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22551499</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Prev Med. 2012 Sep;55(3):246-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22759626</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2013;18(5). pii: 20388</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23399423</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2013 Jul;57(2):167-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23532475</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2013 Oct 15;178(8):1327-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23978527</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2013 Nov;10(11):e1001558</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24302890</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Vaccin Immunother. 2015;11(7):1626-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25996366</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2002 Mar 15;20(13-14):1831-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11906772</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2003 Jan 8;289(2):179-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12517228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2003 May 12;163(9):1089-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12742808</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2004 Jun 2;22(17-18):2192-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15149776</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2004 Sep 1;160(5):492-502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15321847</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 1993 Oct 27;270(16):1956-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8411553</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Castilla, Jesus" sort="Castilla, Jesus" uniqKey="Castilla J" first="Jesús" last="Castilla">Jesús Castilla</name>
<name sortKey="Delfrade, Josu" sort="Delfrade, Josu" uniqKey="Delfrade J" first="Josu" last="Delfrade">Josu Delfrade</name>
<name sortKey="Ezpeleta, Carmen" sort="Ezpeleta, Carmen" uniqKey="Ezpeleta C" first="Carmen" last="Ezpeleta">Carmen Ezpeleta</name>
<name sortKey="Guevara, Marcela" sort="Guevara, Marcela" uniqKey="Guevara M" first="Marcela" last="Guevara">Marcela Guevara</name>
<name sortKey="Irisarri, Fatima" sort="Irisarri, Fatima" uniqKey="Irisarri F" first="Fátima" last="Irisarri">Fátima Irisarri</name>
<name sortKey="Martinez Baz, Ivan" sort="Martinez Baz, Ivan" uniqKey="Martinez Baz I" first="Iván" last="Martínez-Baz">Iván Martínez-Baz</name>
<name sortKey="Moreno Iribas, Conchi" sort="Moreno Iribas, Conchi" uniqKey="Moreno Iribas C" first="Conchi" last="Moreno-Iribas">Conchi Moreno-Iribas</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000185 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000185 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:26222861
   |texte=   Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:26222861" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021